Korea Pharma Co., Ltd. and Glaxo SmithKline Korea signed a contract for GSK’s skin care products and had a signing ceremony to make strong partnership on Apr. 30, 2012.
According to the agreement, Korea Pharma Co., Ltd. will manufacture GSK’s skin care products including LactiCare HC Lotion, LactiCare Zemagis Lotion, Dangard Suspension in its Hyangnam manufacturing facility, and these products will be supplied to the domestic market and also to six Asian countries, Taiwan, Singapore, Vietnam, Thailand, Sri Lanka, and Philippines, for GSK.
This agreement has a lot of meaning to Korea Pharma Co., Ltd.
Korea Pharma Co., Ltd. has been keeping developing their own manufacturing facility, quality control system and high technology since 1974, and for that reason, this agreement is a result of Korea Pharma Co., Ltd’s constant efforts.